197 related articles for article (PubMed ID: 35380160)
21. A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities.
Vaughan D; Mitchell R; Kretz O; Chambers D; Lalowski M; Amthor H; Ritvos O; Pasternack A; Matsakas A; Vaiyapuri S; Huber TB; Denecke B; Mukherjee A; Widera D; Patel K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33408083
[TBL] [Abstract][Full Text] [Related]
22. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.
Oshima Y; Ouchi N; Shimano M; Pimentel DR; Papanicolaou KN; Panse KD; Tsuchida K; Lara-Pezzi E; Lee SJ; Walsh K
Circulation; 2009 Oct; 120(16):1606-15. PubMed ID: 19805648
[TBL] [Abstract][Full Text] [Related]
23. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
24. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.
Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C
Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624
[TBL] [Abstract][Full Text] [Related]
25. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
[TBL] [Abstract][Full Text] [Related]
26. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
Castillero E; Akashi H; Najjar M; Ji R; Brandstetter LM; Wang C; Liao X; Zhang X; Sperry A; Gailes M; Guaman K; Recht A; Schlosberg I; Sweeney HL; Ali ZA; Homma S; Colombo PC; Ferrari G; Schulze PC; George I
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H378-H390. PubMed ID: 31886717
[TBL] [Abstract][Full Text] [Related]
27. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
28. Nur77 protects against adverse cardiac remodelling by limiting neuropeptide Y signalling in the sympathoadrenal-cardiac axis.
Medzikovic L; van Roomen C; Baartscheer A; van Loenen PB; de Vos J; Bakker ENTP; Koenis DS; Damanafshan A; Creemers EE; Arkenbout EK; de Vries CJM; de Waard V
Cardiovasc Res; 2018 Oct; 114(12):1617-1628. PubMed ID: 29850786
[TBL] [Abstract][Full Text] [Related]
29. Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.
Ma W; Liang F; Zhan H; Jiang X; Gao C; Zhang X; Zhang K; Sun Q; Hu H; Zhao Z
Acta Physiol (Oxf); 2020 Oct; 230(2):e13519. PubMed ID: 32480429
[TBL] [Abstract][Full Text] [Related]
30. Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
Deng W; Jiang D; Fang Y; Zhou H; Cheng Z; Lin Y; Zhang R; Zhang J; Pu P; Liu Y; Bian Z; Tang Q
J Mol Histol; 2013 Oct; 44(5):575-85. PubMed ID: 23719775
[TBL] [Abstract][Full Text] [Related]
31. Sulfasalazine exacerbates angiotensin II-induced cardiac remodelling by activating Akt signal pathway.
Chen C; Zhang X; Zheng C; Gao Z; Jiang X; Bai Y; Meng Y
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):776-783. PubMed ID: 35538895
[TBL] [Abstract][Full Text] [Related]
32. Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.
Li L; Wang X; Chen W; Qi H; Jiang DS; Huang L; Huang F; Wang L; Li H; Chen X
Basic Res Cardiol; 2015 Nov; 110(6):56. PubMed ID: 26463597
[TBL] [Abstract][Full Text] [Related]
33. p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice.
Villeneuve C; Guilbeau-Frugier C; Sicard P; Lairez O; Ordener C; Duparc T; De Paulis D; Couderc B; Spreux-Varoquaux O; Tortosa F; Garnier A; Knauf C; Valet P; Borchi E; Nediani C; Gharib A; Ovize M; Delisle MB; Parini A; Mialet-Perez J
Antioxid Redox Signal; 2013 Jan; 18(1):5-18. PubMed ID: 22738191
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction.
Pistilli EE; Bogdanovich S; Mosqueira M; Lachey J; Seehra J; Khurana TS
Am J Physiol Regul Integr Comp Physiol; 2010 Jan; 298(1):R96-R103. PubMed ID: 19864340
[TBL] [Abstract][Full Text] [Related]
35. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice.
Spurthi KM; Sarikhani M; Mishra S; Desingu PA; Yadav S; Rao S; Maity S; Tamta AK; Kumar S; Majumdar S; Jain A; Raghuraman A; Khan D; Singh I; Samuel RJ; Ramachandra SG; Nandi D; Sundaresan NR
J Biol Chem; 2018 Aug; 293(34):13073-13089. PubMed ID: 29929978
[TBL] [Abstract][Full Text] [Related]
37. DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice.
de Boer M; Te Lintel Hekkert M; Chang J; van Thiel BS; Martens L; Bos MM; de Kleijnen MGJ; Ridwan Y; Octavia Y; van Deel ED; Blonden LA; Brandt RMC; Barnhoorn S; Bautista-Niño PK; Krabbendam-Peters I; Wolswinkel R; Arshi B; Ghanbari M; Kupatt C; de Windt LJ; Danser AHJ; van der Pluijm I; Remme CA; Stoll M; Pothof J; Roks AJM; Kavousi M; Essers J; van der Velden J; Hoeijmakers JHJ; Duncker DJ
Aging Cell; 2023 Mar; 22(3):e13768. PubMed ID: 36756698
[TBL] [Abstract][Full Text] [Related]
38. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
39. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
40. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
Zuo C; Li X; Huang J; Chen D; Ji K; Yang Y; Xu T; Zhu D; Yan C; Gao P
Cardiovasc Res; 2018 Apr; 114(5):703-712. PubMed ID: 29415171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
